Navigation Links
Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials
Date:10/18/2018

Predicine, a molecular insights company, announced today that its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received accreditation from the College of American Pathologists (CAP) for meeting the highest standards in quality, operations, and patient safety.

Predicine received CAP accreditation for its Shanghai facility last month. The current dual CAP accreditation of its laboratories in U.S and China enables the company to offer harmonized biomarker assays to its biopharma partners to support clinical trials in China and worldwide. In this setting, all patient samples collected in China will be locally processed in the Shanghai laboratory and samples collected outside of China will be shipped to and processed in the Hayward, California laboratory.

“The dual distinction of being CLIA-certified and CAP-accredited demonstrates our commitment to uphold the industry’s most stringent requirements in laboratory testing for our harmonized assays,” said Dr. Shidong Jia, Founder and CEO of Predicine. “Gaining identical CAP accreditation for both our Shanghai and Hayward facilities enables us to provide a unified quality management system to fully support our partners’ global clinical trials.”

Predicine has developed a propriety GeneRADAR liquid biopsy technology to detect genetic cancer variants in circulation using blood and urine samples. Most recently, Predicine launched an RUO 600-gene TMB liquid biopsy panel at AACR and partners with world-leading biopharmaceutical companies to support global clinical trials in U.S., Europe, Australia, and China.

About Predicine

Predicine is a molecular insights company that is committed to developing the best-in-class precision diagnostics and precision medicine portfolio to address the unmet medical needs worldwide. Predicine’s proprietary GeneRADAR technology is the industry’s first ctDNA+ctRNA combo liquid biopsy test to provide a comprehensive understanding of the molecular alterations in cancer. Through its integrated one-stop biomarker service facilities in US (California) and China (Shanghai, Harbin), Predicine partners with leading biopharma companies and hospitals to support global clinical trials, early cancer screening, and targeted therapy. For more, please visit predicine.com and follow Predicine on Twitter @Predicine.

Read the full story at https://www.prweb.com/releases/predicine_establishes_dual_cap_accreditation_for_its_genomic_sequencing_laboratories_in_us_and_china_to_support_global_clinical_trials/prweb15850777.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Predicine and Flagship Biosciences Partner to Support Global Biomarker Development
2. The Center for Advancing Innovation Establishes Ambassador Program
3. Western IRB Establishes Single-IRB Solution to Help Institutions Comply with New Mandate for NIH-Funded Research
4. Johnson & Johnson Establishes Susan Lindquist Chair for Women in Science
5. SenzaGen establishes subsidiary in the US
6. Global Pneumatic Tube System Provider Aerocom Establishes North American Office to Focus on Hospital Market
7. Evelo Therapeutics Establishes Core Executive Team
8. INSYS Group Establishes National Healthcare Practice
9. Ember Therapeutics Raises up to $6M and Establishes Commercial Partnership with Knight Therapeutics
10. ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
11. Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2019)... BARBARA, Calif. (PRWEB) , ... March 18, 2019 , ... ... have partnered together to develop solutions that allow life science companies to easily comply ... requirements. USDM’s Cloud Assurance ™ is a managed service delivering end-to-end GxP compliance ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The growth ... challenges for companies to keep up. Traditional Regulatory intelligence (RI) ... adapting technology to get global Regulatory teams right Insights faster and cheaper. With a ...
(Date:3/14/2019)... MURRIETA, Calif. (PRWEB) , ... March 13, 2019 , ... ... Advisory Board. The Board will bring industry specific and broader business experience to bear ... the incubator to have access to the knowledge and expertise that our Advisory Board ...
(Date:3/12/2019)... ... March 11, 2019 , ... Centura ... Colorado, and among the first in the nation, to offer needle-free blood draws ... placement and overall degree to which staff showed compassion jumped up by an ...
Breaking Biology Technology:
(Date:2/27/2019)... , ... February 27, 2019 , ... Fluxion Biosciences, a ... it has received a National Cancer Institute grant for further development of its ERASE-Seq ... with clinical support from the lab of Dr. Omar Mian at the Cleveland Clinic. ...
(Date:2/26/2019)... ... February 26, 2019 , ... Ms. Baptiste has ... Account Manager, Ms. Baptiste demonstrated her ability to advocate for the Lifecycle customer ... responsible for partnering with both the Strategic Development team and the Operations team ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... precision medicine, the traditional line between engineering and medical science grows ever thinner. ... smarter, the medical device industry is making medical practice easier for doctors, more ...
Breaking Biology News(10 mins):